Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness

Title
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 101, Issue 2, Pages 238-243
Publisher
Springer Nature
Online
2009-07-01
DOI
10.1038/sj.bjc.6605167

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation